🧫
experiment
Early disease phase characterized by remyelination response from oligodendrocyte precursor cells.
🧫 Experiment Protocol
Cell Biology
Alzheimer's disease
human
extracted
PRIMARY OUTCOME
Early disease phase characterized by remyelination response from oligodendrocyte precursor cells.
LINKED HYPOTHESES
h-aging-opc-elf2
· ELF2-Mediated OPC Epigenetic Drift Drives Region-Dependent Myelin Dysfunction
Source: pmid_39402379
🧫 Experiment Extras
PATHWAY
myelination
MARKET PRICE
$0.50
STATUS
extracted
View on SciDEX ↗